Logo

Croup is a common respiratory illness caused by a viral infection in the airway. Accompanied by a barky cough and respiratory distress, this illness is most common in children aged birth to 6 years, peaking at 2 years of age.

BROWSE EVIDENCE REPOSITORY

 

Systematic reviews English (5) French All (5)

Cochrane Systematic Review: Glucocorticoids for croup in children

Visit

Gates A, Gates M, Vandermeer B, Johnson C, Hartling L, Johnson DW, Klassen TP,

Objective: To examine the effects of glucocorticoids for the treatment of croup in children aged 0 to 18 years. Published: 2018.

Cochrane Systematic Review: Heliox for croup in children

Visit

Moraa I, Sturman N, McGuire TM, van Driel ML,

Objective: To examine the effect of heliox compared to oxygen or other active interventions, placebo, or no treatment, on relieving signs and symptoms in children with croup as determined by a croup score and rates of admission and intubation.

Cochrane Systematic Review: Nebulized epinephrine for croup in children

Visit

Bjornson, C, Russell, K, Vandermeer, B, Klassen, TP, Johnson, DW,

Objective: To assess the efficacy (measured by croup scores, rate of intubation and health care utilization such as rate of hospitalization) and safety (frequency and severity of side effects) of nebulized epinephrine versus placebo in children with croup, evaluated in an emergency department (ED) or hospital setting.

Review: Croup in children

Visit

Bjornson CL, Johnson DW,

Objective:This review will address the diagnosis and management of croup in children, specifically focusing on clinical assessment of disease severity to guide management decisions.

Cochrane Systematic Review: Humidified air inhalation for treating croup

Visit

Moore, M, Little, P,

Objective: To assess the efficacy of humidified air in the treatment of croup.

Cochrane Systematic Review: Glucocorticoids for croup in children

Visit

Gates A, Gates M, Vandermeer B, Johnson C, Hartling L, Johnson DW, Klassen TP,

Objective: To examine the effects of glucocorticoids for the treatment of croup in children aged 0 to 18 years. Published: 2018.

Cochrane Systematic Review: Heliox for croup in children

Visit

Moraa I, Sturman N, McGuire TM, van Driel ML,

Objective: To examine the effect of heliox compared to oxygen or other active interventions, placebo, or no treatment, on relieving signs and symptoms in children with croup as determined by a croup score and rates of admission and intubation.

Cochrane Systematic Review: Nebulized epinephrine for croup in children

Visit

Bjornson, C, Russell, K, Vandermeer, B, Klassen, TP, Johnson, DW,

Objective: To assess the efficacy (measured by croup scores, rate of intubation and health care utilization such as rate of hospitalization) and safety (frequency and severity of side effects) of nebulized epinephrine versus placebo in children with croup, evaluated in an emergency department (ED) or hospital setting.

Review: Croup in children

Visit

Bjornson CL, Johnson DW,

Objective:This review will address the diagnosis and management of croup in children, specifically focusing on clinical assessment of disease severity to guide management decisions.

Cochrane Systematic Review: Humidified air inhalation for treating croup

Visit

Moore, M, Little, P,

Objective: To assess the efficacy of humidified air in the treatment of croup.